Location & dates EMBL Heidelberg, Germany 7 - 10 Jun 2013
Deadlines Registration closed Abstract submission closed
EES_logo

EMBL Courses and Conferences during the Coronavirus pandemic

With the onsite programme paused, many of our events are now being offered in virtual formats.


Registration is open as usual for many events, with back-up plans in place to move further courses and conferences online as necessary. Registration fees for any events affected by the COVID-19 disruption are fully refundable.


More information for participants of events at EMBL Heidelberg can be found here.

Latest News

  • Registration deadline - 9 May 2013

  • Preliminary Programme is available

 

Why You Should Attend

Summary

Regenerative medicine is a prime example of the interdisciplinary trend in contemporary biomedical research, incorporating developmental and stem cell biology, biomaterials and tissue engineering, gene and cell therapeutic approaches. The science underpinning recent advances in tissue repair has already provided significant clinical outcomes in many organ systems, yet the challenges facing regeneration of the cardiovascular system are particularly complex. The mature mammalian heart is particularly refractory to recovery after insult, mysteriously losing the robust cardiac regenerative capacity of the embryo, which is retained by other species into adulthood.

Aims of event

This conference will cover recent discoveries in cardiac developmental biology, compare cardiac systems across the evolutionary spectrum, and explore the fundamental barriers to cardiac self-renewal in the clinical context. International specialists will share their latest work in this challenging field, focusing on the interface of basic and translational research.

Topics

- Heart development and evolution

- Cardiovascular disease

- Heart regenerative strategies

- Therapeutic approaches 

Who should attend

Developmental Biologists, Cardiac Biologists, Cardiologists, Cardiothoraric Surgeons, Pediatric Cardiologists